| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |